BAJAJ BROKING

Notification close image
No new Notification messages
card image
3B Films IPO is Open!
Apply for the 3B Films IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

Apollo Hospitals Q4 Results FY24-25: Net Profit Rises 53.5%, Revenue Up 13%

Synopsis:

Apollo Hospitals posted a 53.5% YoY rise in net profit to Rs.390 crore in Q4 FY25, exceeding Street estimates. Revenue grew 13% to Rs.5,592 crore. The board declared a final dividend of Rs.10 per share, with a record date set for August 19, 2025.


Apollo Hospitals Enterprise delivered a strong Q4 FY25, reporting a net profit of Rs.390 crore, up 53.5% from Rs.254 crore in the same quarter last year. Revenue from operations increased 13% YoY to Rs.5,592 crore, compared to Rs.4,944 crore in Q4 FY24.

Sequentially, net profit rose 5% from Rs.372 crore in Q3 FY25, while revenue showed a modest 1.2% growth over Rs.5,527 crore in the previous quarter. Total expenses increased to Rs.5,148 crore in Q4 from Rs.4,612 crore in Q4 FY24, reflecting higher input, staffing, and finance costs.

The board recommended a final dividend of Rs.10 per equity share for FY25, with the record date fixed as August 19, 2025.

APOLLO HOSPITALS ENTER. L

Trade

687621.00 (0.30 %)

Updated - 05 June 2025
6919.50day high
DAY HIGH
6842.00day low
DAY LOW
488647
VOLUME (BSE)

Key highlights and takeaways

  • Q4 FY25 net profit grew 53.5% YoY to Rs.390 crore.

  • Revenue from operations rose 13% YoY to Rs.5,592 crore.

  • Sequential net profit rose 5% from Rs.372 crore in Q3 FY25.

  • Expenses climbed to Rs.5,148 crore from Rs.4,612 crore in Q4 FY24.

  • Final dividend of Rs.10 per share announced; record date set as August 19, 2025.

  • Net profit beat Street expectations of Rs.374 crore.

Management commentary and strategic outlook

Apollo Hospitals’ strong performance this quarter reflects its continued leadership in healthcare services and growth in digital healthcare platforms. Focused execution, cost optimisation, and scale benefits helped deliver stronger-than-expected earnings.

The company is expected to build further on its integrated care ecosystem — spanning hospitals, diagnostics, pharmacies, and digital engagement through Apollo 24/7 — to drive future profitability. Ongoing investments in specialty care, regional expansion, and technology adoption remain key pillars of its FY26 strategy.

Sector expectations and business outlook

India’s healthcare sector is witnessing rising demand, led by urbanisation, insurance penetration, and increased public-private collaboration. Large hospital chains like Apollo are likely to benefit from operating leverage, digital health integration, and increasing outpatient and elective procedure volumes.

With tailwinds from policy support and rising medical tourism, Apollo is well-placed to sustain growth in FY26, supported by scale, brand trust, and clinical excellence.

Apollo Hospitals consolidated financial table

Metric

Q4 FY25

Q4 FY24

Q3 FY25

Net profit (Rs. crore)

390.0

254.0

372.0

Revenue from operations

5,592.0

4,944.0

5,527.0

Total expenses

5,148.0

4,612.0

5,060.0

Dividend per share (Rs.)

10.00*

Record date

19 Aug 2025

*Final dividend for FY25 as per board recommendation.

Source: Apollo Hospitals Enterprise Ltd – Audited Q4 FY25 Financial Results & Stock Exchange Filings

Share this article: 

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

10 lakh+ Users

icon-with-text

4.4 App Rating

icon-with-text

4 Languages

icon-with-text

₹5100+ Cr MTF Book

icon-with-text